Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Ethics and Feasibility of Randomized Trials of Diagnostic Technology: A Reply
1
Zitationen
2
Autoren
1985
Jahr
Abstract
Drs. Weinstein and Wulff (in issue 1:3) have raised legitimate and important concerns about the ethical acceptability and feasibility of randomized control trials (RCTs) of diagnostic technologies. Their criticisms are all the more compelling in light of their strong advocacy of rigorous evaluation, and their insights into the advantages of RCTs and potential problems with alternative approaches as outlined with great clarity in Dr. Weinstein's paper. We shall not attempt a point by point rebuttal (partly because we are in full or partial agreement with most of their comments) but instead will highlight several issues which we believe merit further discussion.
Ähnliche Arbeiten
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
2003 · 10.819 Zit.
Estimating the mean and variance from the median, range, and the size of a sample
2005 · 8.927 Zit.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 · 6.943 Zit.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
2020 · 5.219 Zit.
The global landscape of AI ethics guidelines
2019 · 4.502 Zit.